Chugai Pharmaceutical Co (JP:4519) has released an update.
Chugai Pharmaceutical Co., Ltd. reports a solid performance in the first half of FY 2024, with notable increases in net income and earnings per share compared to the previous year. Despite a slight decline in revenue, the company saw an 18.9% rise in net income and a positive shift in earnings per share from ¥95.25 to ¥113.20. Shareholders also benefit from a dividend increase, with the forecasted total for FY 2024 set at ¥82.00 per share.
For further insights into JP:4519 stock, check out TipRanks’ Stock Analysis page.
